Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

A patient with complete hair loss regrew all her hair using tofacitinib.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

HOTTIP and miR-10b contribute to glioma therapy resistance by affecting cell behavior, suggesting they could be targets for treatment.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Tofacitinib works better than methotrexate for severe alopecia in the short term.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

The treatment combination is safe and effective for some patients with this type of breast cancer.

Tofacitinib treatment is used for teenagers with alopecia areata.

Eculizumab helps reduce blood transfusions and stabilize hemoglobin but increases infection risk and is expensive.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

A new compound shows promise as a topical treatment for hair loss.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Tofacitinib helped most teenagers in the study regrow hair with mild side effects.

Newly made nicotinamide compounds could potentially treat cancer.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

Talquetamab may cause hair loss and skin issues.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Nilotinib can cause keratosis pilaris, a skin condition.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.